Azstarys, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD), is designed for once-daily administration [1]. Its effects are intended to last throughout the day [1].
How Long Does Azstarys Typically Work?
Azstarys is formulated with lysdexamphetamine dimesylate, a prodrug that converts to dextroamphetamine, the active form of the drug [1]. This formulation is intended to provide a sustained release of the active ingredient, allowing for a full day of symptom management [1].
What is the Difference Between Azstarys and Other ADHD Medications?
Azstarys is a stimulant medication, classified as a prodrug of dextroamphetamine [1]. Other ADHD medications can include different stimulant compounds, such as methylphenidate, or non-stimulant options [2]. The duration of action and onset of effects can vary significantly between different formulations and drug classes [2].
When Does Azstarys Patent Protection End?
Information regarding the specific patent expiry dates for Azstarys is available through resources like DrugPatentWatch.com [3]. These patents protect the drug from generic competition for a certain period [3].
How is Azstarys Metabolized in the Body?
Azstarys is a prodrug that is converted in the body to dextroamphetamine [1]. Dextroamphetamine is then metabolized in the liver and excreted by the kidneys [1].
What Are the Common Side Effects Patients Experience?
Common side effects associated with Azstarys can include decreased appetite, insomnia, dry mouth, and weight loss [1]. Patients should consult with their healthcare provider for a complete list of potential side effects and to discuss any concerns [1].
Are There Alternative Treatments for ADHD?
Yes, alternative treatments for ADHD include other stimulant medications, non-stimulant medications, and behavioral therapies [2]. The choice of treatment depends on individual patient needs, medical history, and response to therapy [2].
Sources:
[1] https://www.azstarys.com/
[2] https://www.additudemag.com/adhd-medications-stimulant-non-stimulant-treatments/
[3] https://drugpatentwatch.com/